News &
Events

 

Latest News

TAU Momentum Fund with another spin off Company - QART Medical finalizes round of venture investment

QART (Quantitative Assisted Reproductive Technologies) Medical, is a clinical-stage MedTech company, addressing the global infertility epidemic.

Tel Aviv, Israel, March 19, 2019, Tel Aviv University (TAU), Technology Innovation Momentum Fund, managed by Ramot, TAU’s Business Engagement Center and Chartered Investment Managers, a SEA-based investment management fund announced the completion of an investment round in QART Medical.

Read More

Collaboration Agreement with Phylogica - siRNA delivery

Phylogica has entered into a Research and Development Collaboration with Ramot, the Business Engagement Center at Tel Aviv University to further develop the research of Professor Dan Peer of Tel Aviv University in Israel.

Read More

Trobix Bio – a new company launched to tackle antimicrobial resistance

Tel Aviv, Israel, March 6, 2019, Tel Aviv University (TAU), Technology Innovation Momentum Fund, managed by Ramot, TAU’s Business Engagement Center has entered into a license agreement with Trobix Bio, a newly formed start-up company, to develop and commercialize its antimicrobial resistance platform technology. Following the license agreement, Trobix Bio has completed its initial funding round, led by Chartered Opus investment group.

Read More

Ramot Newsletter December 2018

Read More